Imgen BioSciences, Inc. is a biotechnology company focused on the discovery and development of diagnostic and immunotherapeutic agents in the fields of cancer, infectious diseases, and food safety rapid tests. The company also provides services for immunogenecity studies, molecular cloning, and the production of immune receptors and recombinant antibodies.


News

Imgen's Founder and President Dr. Wendell Yang as a first inventor granted a US patent on CAR-T related technology, Dec., 2015     [PDF]
Biomanufacturing keeps moving along on SouthCoast Sept., 2014     [PDF]
Imgen supports Massachusetts Life Sciences Center Internship 2013     [PDF]